Exelixis (EXEL) Tops Q2 EPS by 30c
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $50.61 +0.46%
Financial Fact:
Research and development: 22.98M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 22.98M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.37, $0.30 better than the analyst estimate of $0.07. Revenue for the quarter came in at $385.2 million versus the consensus estimate of $298.16 million.
GUIDANCE:
Exelixis sees FY2021 revenue of $1.3-1.4 billion, versus the consensus of $1.23 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- zSpace, Inc. (ZSPC) Reports Q2 results
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
